Health news from Israel
Woman in her 40s dies after amniotic fluid embolism during childbirth; baby safely delivered
A woman in her 40s with no background illnesses developed an amniotic fluid embolism during labor at Maayanei HaYeshua Medical Center in Bnei Brak and underwent prolonged resuscitation.
More stories
Boiling Requirement for Water in Nazareth Lifted After Clean Test Results
The Health Ministry announced the cancellation of the water boiling requirement in Nazareth after water tests in the city came back clean. The water is now fit for drinking and all other uses.
Concern over optic nerve damage in weight-loss drugs: FDA orders warning to be added
The US Food and Drug Administration (FDA) has ordered a warning to be added to the labels of GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, over a possible risk of rare damage to the optic nerve that could cause permanent vision loss. A causal link between the drugs and the condition has not yet been proven.
Two-year-old girl hospitalized in intensive care with a complication of influenza
A two-year-old girl, with no background illnesses and not vaccinated against influenza, is hospitalized in the pediatric intensive care unit at Shaare Zedek Medical Center in Jerusalem due to a rare complication of the illness. Her condition is stable and improving, according to the hospital.
Bathing Warning Lifted on Most Mediterranean Beaches, Except Beaches in Tel Aviv, Herzliya and Ashdod
The Ministry of Health announced that the bathing warning has been lifted from most Mediterranean beaches. The warning remains in effect at Charles Clore Beach in Tel Aviv, at all beaches in Herzliya, and at Mei Ami Beach in Ashdod, after water test results at those sites were found to be satisfactory.
Cipralex, Cymbalta and Agomelatine Showed Better Results Than Prozac in Long-Term Depression Treatment
An analysis of 115 randomized trials, which included more than 30,000 adults with major depression and 21 drugs, found that Cipralex, Cymbalta and Agomelatine showed better results than Prozac in long-term treatment. The researchers said there is no reason to switch a medication that is already helping the patient.
Google to Fund Development of AI Assistant for Clalit Health Services
Google will transfer a grant of $2 million to Clalit Health Services to develop a voice-based artificial intelligence assistant for patients. The system will enable scheduling appointments, reporting symptoms and receiving medical guidance, and will launch initially as a pilot.
